Kymera legal chief sold shares worth more than $744K
Brian Adams, Chief Legal Officer at Kymera Therapeutics, sold shares of common stock on September 4, 2026, to cover tax withholding tied to restricted stock unit vesting. Shares sold were worth over $744K.